Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia
about
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5qInositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cellsRNA interference of interferon regulatory factor-1 gene expression in THP-1 cell line leads to Toll-like receptor-4 overexpression/activation as well as up-modulation of annexin-IIStructure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon systemThe cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseasesDocking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIPIntracellular activation of interferon regulatory factor-1 by nanobodies to the multifunctional (Mf1) domainCooperative regulation of the interferon regulatory factor-1 tumor suppressor protein by core components of the molecular chaperone machineryImpact of protein kinase PKR in cell biology: from antiviral to antiproliferative actionThe IRF family, revisitedAnti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2Identification of a conserved family of Meis1-related homeobox genesNuclear factor kappa B is involved in lipopolysaccharide-stimulated induction of interferon regulatory factor-1 and GAS/GAF DNA-binding in human umbilical vein endothelial cellsInterferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infectionA retroviral library genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth suppression in leukemic cells.Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study.Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.The IRF-3 transcription factor mediates Sendai virus-induced apoptosisAltered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection.Expression of interferon regulatory factor 1 and 2 in hematopoietic cells of children with juvenile myelomonocytic leukemia.Inactivation of a single copy of Crebbp selectively alters pre-mRNA processing in mouse hematopoietic stem cells.Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.Cytokine-induced tumor suppressors: a GRIM storyA novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31.A novel role for interferon regulatory factor 1 (IRF1) in regulation of bone metabolismThe class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.Therapy related leukemias: susceptibility, prevention and treatment.GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.Receptor tyrosine kinase mutations in myeloid neoplasms.Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosusInterferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.Cytokine therapeutics: lessons from interferon alphaLoss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.Identification and characterization of HTLV-1 HBZ post-translational modifications.Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.
P2860
Q22254660-072016FE-09FA-423C-9B88-945DDF1284FDQ24291206-4B35964D-B81D-4108-87EF-9D10F1CE0267Q24303890-BF9D1337-E01D-4272-89AE-C427C0640F01Q24305003-48848F9A-1603-4090-BADD-2D88A7370BA5Q24309232-FA006AC3-0C85-40F4-9BC7-929D1DD484AFQ24310030-62568C25-11FF-4655-87A9-08B20C12DBFFQ24537405-3BC98094-3180-4388-B8EE-5B9EE7DD3695Q24562724-F02E6A6F-D58C-4FCA-9089-AA1257637CF5Q24617588-86F44A6F-0C43-4F08-9DB7-401746534F1AQ24634375-117D6D06-D311-4C96-A5CC-AF250C309EC1Q24656529-D2277581-02C2-41CE-9F5F-FA01054AE538Q24672548-F696181A-E387-4D84-A859-44DCE00E3D22Q24678497-AC08F3A5-0768-4CA5-A8FF-076DB377DA79Q28118615-8A395A21-8CEA-4829-BFCC-BCC146DD42F9Q28304621-540BAB5A-8BE9-412C-91D5-F1E0D7E302B3Q28366024-120862A6-4CCA-4A00-B217-C2548A5F8FABQ28508364-6AEAE940-5073-4E71-AF9A-83A7191A76FCQ33218585-576876FB-6E3B-4EA2-9697-FCD1A58B35A3Q33489476-8F5E8D51-8B68-4A41-AAB3-9FAA7A86623CQ33649357-12B15731-6D0B-4D33-8A57-ADBD64341D71Q33781496-A8465A9D-4174-4FF2-AE3E-B6D69946196BQ33802650-2E93FED9-755F-4277-BC81-4142466D420FQ33867065-E360531B-8839-4374-BE55-B9765F4AFD45Q33884620-2953520E-CD1A-4C27-9E5A-27B4630EBC14Q34013832-7197E660-065C-45A7-A7CC-5D0BAAB5CEC8Q34028179-BD652A3D-046E-4AB6-B1E5-AF188B5E1A8AQ34077445-68D9C424-26CD-4DBD-B448-3BDB93AEDF47Q34099938-AE28C38E-7B13-4E8F-A0E3-31FC7D02094FQ34122992-7C331B0E-A510-44C6-AAFF-A8C6EC752265Q34125310-BA473F0D-6A98-4D23-85BA-12BF087024C4Q34139499-926E10C8-0270-4A01-8B89-F7FA385B5941Q34265193-8AC5E50A-13BF-43AA-BD06-66625B6C1BD1Q34497752-88B89DD2-A8E2-435C-8258-A37182FBEAF5Q34655403-50B4F117-B9C8-430A-A0EC-B04514DADA4DQ34672353-29EA4388-8B22-4901-84CE-35B8C7655921Q34979127-6CF505D9-9D9F-47CF-9AA6-DF60B1D777DEQ35033232-94F63301-4A66-4EF6-93F2-213FEC97E5A1Q35197148-7C461315-2843-4921-9929-DEAD1692BE8BQ35412479-CE21072C-12AF-43AC-973A-E0D951685E4CQ35554043-FE2197A5-83DC-475A-98AF-274AA8F4CA4E
P2860
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@ast
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@en
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@nl
type
label
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@ast
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@en
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@nl
prefLabel
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@ast
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@en
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@nl
P2093
P2860
P356
P1433
P1476
Deletion of IRF-1, mapping to ...... and preleukemic myelodysplasia
@en
P2093
C L Willman
H Yamamoto
M G Pallavicini
M L Slovak
T C Meeker
P2860
P304
P356
10.1126/SCIENCE.8438156
P407
P577
1993-02-12T00:00:00Z